Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care
Open Access
Abstract
Background/Objectives: Recently, the Herpes Zoster (HZ) vaccination has been introduced, alongside influenza and pneumococcal vaccination, at age 65. Factors influencing adherence to this vaccination and its clinical benefits are not completely understood. The aim of this study was to evaluate factors influencing adherence to HZ vaccination compared to pneumococcal and influenza and to assess its clinical effect in preventing acute vascular events. Methods: A total of 1152 patients (520 males), having a birth cohort from 1952 to 1959 inclusive, was recruited, belonging to the District of Udine (N = 839) and to the ASAPs 2 and 3 of Pordenone (N = 313). For each patient, a form was compiled. Results: HZ vaccination was administered to 498 patients, influenza to 665, and pneumococcal to 742 (p < 0.0001). Among the vaccinated, 266 received the live-attenuated version, and 232 the recombinant HZ vaccine. In logistic regression, the presence of addictions, low educational level, and poor socioeconomic status were strongly associated with lower vaccine adherence. The presence of chronic diseases enhanced only pneumococcal (p < 0.001) and influenza (p < 0.001) vaccine adherence. Forty-two non-fatal acute vascular events were recorded from age 65 onwards: 14 cardiac, 20 cerebrovascular, and 8 peripheric. Only 6/493 patients experienced an event following HZ vaccination compared to 36/659 unvaccinated subjects (p = 0.0003). In Cox modeling, HZ vaccination proved to be an independent predictor in preventing subsequent acute vascular events (p < 0.001). Conclusions: The presence of pathologies does not enhance adherence to HZ vaccination while an unfavorable socio-environmental context greatly hinders it. HZ vaccination, but not influenza and pneumococcal vaccination, appears to protect against the occurrence of acute vascular events.Keywords
This publication has 65 references indexed in Scilit:
- Herpes Zoster Vaccination and Dementia OccurrenceJAMA, 2025
- Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in BelgiumEpidemics, 2025
- Time-varying association between herpes zoster infection and subsequent occurrence of strokePublic Health, 2024
- Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studiesActa Diabetologica, 2023
- Risk of, and risk factors for, vasculopathy associated with acute herpes zosterJournal of Stroke and Cerebrovascular Diseases, 2022
- Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
- Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-AnalysisJournal of Stroke and Cerebrovascular Diseases, 2017
- Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesisJournal of Neuroimmunology, 2017
- Zeroing in on zoster: A tale of many disorders produced by one virusJournal of the Neurological Sciences, 2015
- Validity and reliability of a survey to identify vaccine-hesitant parentsVaccine, 2011